Show simple item record

dc.contributor.authorPerim Rodrigues, Leane
dc.contributor.authorRodrigues Teixeira, Vitória
dc.contributor.authorAlencar-Silva, Thuany
dc.contributor.authorSimonassi-Paiva, Bianc
dc.contributor.authorWellerson Pereira, Rinaldo
dc.contributor.authorPogue, Robert
dc.contributor.authorLott Carvalho, Juliana
dc.date.accessioned2023-01-17T15:06:46Z
dc.date.available2023-01-17T15:06:46Z
dc.date.copyright2022
dc.date.issued2022-06
dc.identifier.citationPerim Rodrigues, L., Rodrigues Teixeira, V., Alencar-Silva, T., Simonassi-Paiva, B., Pereira, R.W., Pogue, R., Lott Carvalho, J. (2022). Hallmarks of aging and immunosenescence: connecting the dots. Cytokine and Growth Factor Reviews. 59, 9-21.en_US
dc.identifier.issn1359-6101
dc.identifier.urihttps://research.thea.ie/handle/20.500.12065/4365
dc.description.abstractAging is a natural physiological process that features various and variable challenges, associated with loss of homeostasis within the organism, often leading to negative consequences for health. Cellular senescence occurs when cells exhaust the capacity to renew themselves and their tissue environment as the cell cycle comes to a halt. This process is influenced by genetics, metabolism and extrinsic factors. Immunosenescence, the aging of the immune system, is a result of the aging process, but can also in turn act as a secondary inducer of senescence within other tissues. This review aims to summarize the current state of knowledge regarding hallmarks of aging in relation to immunosenescence, with a focus on aging-related imbalances in the medullary environment, as well as the components of the innate and adaptive immune responses. Aging within the immune system alters its functionality, and has consequences for the person's ability to fight infections, as well as for susceptibility to chronic diseases such as cancer and cardiovascular disease. The senescence-associated secretory phenotype is described, as well as the involvement of this phenomenon in the paracrine induction of senescence in otherwise healthy cells. Inflammaging is discussed in detail, along with the comorbidities associated with this process. A knowledge of these processes is required in order to consider possible targets for the application of senotherapeutic agents - interventions with the potential to modulate the senescence process, thus prolonging the healthy lifespan of the immune system and minimizing the secondary effects of immunosenescence.en_US
dc.formatPDFen_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.ispartofCytokine and Growth Factor Reviewsen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectAgingen_US
dc.subjectSenescenceen_US
dc.subjectImmunosenescenceen_US
dc.subjectInflammagingen_US
dc.subjectSenotherapeuticsen_US
dc.titleHallmarks of aging and immunosenescence: connecting the dotsen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.contributor.affiliationTechnological University of the Shannon: Midlands Midwesten_US
dc.contributor.sponsorConselho Nacional de Desenvolvimento Científico e Tecnologico (CNPq) and Fundaçao de Amparo `a Pesquisa do Distrito Federal (FAPDF).en_US
dc.description.peerreviewyesen_US
dc.identifier.doi10.1016/j.cytogfr.2021.01.006en_US
dc.identifier.eissn1879-0305
dc.identifier.endpage21en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-8486-1275en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-8789-3512en_US
dc.identifier.startpage9en_US
dc.identifier.volume59en_US
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessen_US
dc.subject.departmentBioscience Research Institute TUS: Midlandsen_US
dc.type.versioninfo:eu-repo/semantics/publishedVersionen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States